Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome
Clinical trial NCT02550080 · UNKNOWN
Trial details
- NCT number
- NCT02550080
- Sponsor
- Shandong Provincial Institute of Dermatology and Venereology
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2018-12-01
- Enrollment
- 3130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.